MiR-181b is part of a miRNA signature expressed in cytogenetically normal (CN) AML containing high-risk molecular characteristics (e.g., NPM1 negative, FLT3-ITD positive) and is associated with a good prognosis [141]. This evidence concerns the gene NPM1 and acute myeloid leukemia.